Question to the Department for Exiting the European Union :

To ask the Secretary of State for Exiting the European Union, what estimate he has made of the annual value to the economy from the European Medicines Agency having been located in London in each of the last five years.

We recognise the important role that the European Medicines Agency (EMA) plays in the protection of human and animal health.

In the negotiations the Government will discuss with the EU and Member States how best to continue cooperation in the field of medicines regulation in the best interests of both the UK and the EU.

We have a world class research base and world beating universities and businesses that mean the UK life sciences will continue to thrive. As shown by the recent investment decisions by GSK, Alnylam and Novo Nordisk, the UK remains open for business. It is in the interests of the UK and EU to secure a mutually beneficial agreement for business and citizens across Europe.